Pelvic LN positive | |||
All (n = 67) | Boost to pelvic lymph nodes (n = 36) | No boost to pelvic lymph nodes (n = 31) | |
Recurrence | 27 (40.3%) | 16 (44.5%) | 11 (35.4%) |
Local only | 3 (4.5%) | 2 (5.6%) | 1 (3.2%) |
Distant only | 12 (17.9%) | 8 (22.2%) | 5 (16.1%) |
Local and distant | 12 (17.9%) | 6 (16.7%) | 5 (16.1%) |
No recurrence | 40 (59.7%) | 20 (55.5%) | 20 (64.6%) |
Pelvic LN and para-aortic LN positive | |||
All (n = 9) | Boost to pelvic lymph nodes (n = 7) | No boost to pelvic lymph nodes (n = 2) | |
Recurrence | 6 (66.7%) | 4 (57.1%) | 2 (100%) |
Local only | 0 | 0 | 0 |
Distant only | 2 (22.2%) | 1 (14.2%) | 1 (50%) |
Local and distant | 4 (44.4%) | 3 (42.9%) | 1 (50%) |
No recurrence | 3 (33.3%) | 3 (42.9%) | 0 |